JRCT ID: jRCT1032240550
Registered date:13/12/2024
Evaluation of neuroplasticity and biomarker after neurorehabilitation for Parkinson's disease
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Parkinson's disease |
Date of first enrollment | 12/01/2024 |
Target sample size | 40 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Compared to regular rehabilitation aimed at maintaining daily life and ADL, the rehabilitation in this study focuses on active aerobic exercise, mainly in the sitting and standing positions. Meanwhile, the therapist performs muscle stretches and alignment corrections (body segments and body axes) according to the individual needs of the patient, as well as whole-body coordination, including increasing or decreasing the amount of assistance for unstable elements. In this respect, it differs from the patient simply doing exercises on his or her own. |
Outcome(s)
Primary Outcome | Neuroplasticity determined by comparing head MRI before and after neurorehabilitation and molecular mechanisms related to neuroplasticity determined by integrated analysis of changes in blood exosome profiles |
---|---|
Secondary Outcome | 1) Neuroplasticity obtained by comparing head MRI before and after neurorehabilitation 2) Changes in blood exosome profile (microRNA, mRNA, protein, metabolites, etc.) 3) Changes in PD-related evaluation items HDS-R, MMSE UPDRS part I, II, III, IV Beck Depression Scale Wearing-off Questionnaires19 Sit to stand-5 Time up and go test Functional reach test Mini-Bestest Falls efficacy scale-International |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Both |
Include criteria | 1) PD patients diagnosed by a neurologist based on the UK Parkinson's Disease Society Brain Bank 2) PD patients currently attending our outpatient clinic 3) Yahr severity level 3 or less |
Exclude criteria | 1) Patients under 20 years of age 2) Patients with moderate or higher cognitive function (MMSE < 24) 3) Patients with contraindications for MRI due to pacemakers, metal in the body, or claustrophobia 4) Patients for whom aerobic exercise is deemed inappropriate due to unstable hypertension, diabetes, cerebrovascular disease, heart disease (ischemic heart disease, arrhythmia, heart failure, etc.), peripheral arterial occlusive disease, orthostatic hypotension, pulmonary disease, etc. 5) Patients with neurological or orthopedic diseases who cannot undergo rehabilitation using stretching or an exercise bike 6) Patients with mental disorders such as depression diagnosed by a psychiatrist, or those with significant mental symptoms |
Related Information
Primary Sponsor | Ueno Yuji |
---|---|
Secondary Sponsor | Scholarship donations to the Department of Neurology,Yamanashi University FY2023 Community Contribution Promotion Project |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Yuto Morishima |
Address | Shimokato 1110, Chuo, Yamanashi Yamanashi Japan 409-3898 |
Telephone | +81-55-273-9896 |
ymorishima@yamanashi.ac.jp | |
Affiliation | University of Yamanashi |
Scientific contact | |
Name | Yuji Ueno |
Address | Shimokato 1110, Chuo, Yamanashi Yamanashi Japan 409-3898 |
Telephone | +81-55-273-9896 |
uenoy@yamanashi.ac.jp | |
Affiliation | University of Yamanashi |